Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Know Your Labs

Peter H. Schur, MD  |  

A review of state-of-the-art testing for SLE and connective tissue disease.

Measuring Quality of Care Is Here to Stay—and the ACR Can Help

  |  

Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.

Biologic Logic: Making Sense of Current Therapies for Rheumatic Diseases

  |  

Continuing the ARHP 2009 Audioconference/Webcast series, Daniel F. Battafarano, DO, FACP, FACR, will discuss the use of biologic therapy in the treatment of rheumatology patients on February 10 from noon to 1:00 pm ET. During the session, Dr. Battafarano will review basic immunology, inflammation, and relevant cytokines for common rheumatic diseases. In addition, he will describe the current biologic therapies and their relationship to rheumatic disease outcomes, and identify future biologic strategies for therapy.

The Language of Lawmaking

  |  

Many people shy away from participating in advocacy efforts because they are uncomfortable with the terminology used.

ARHP Presidential Introduction

Pamela J. Degotardi, PhD  |  

As the newly minted president of the ARHP, I’d like to introduce myself.